CENMIRA Trademark

Trademark Overview

On Tuesday, November 15, 2016, a trademark application was filed for CENMIRA with the United States Patent and Trademark Office. The USPTO has given the CENMIRA trademark a serial number of 87237166. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 6, 2020. This trademark is owned by Teva Pharmaceutical Industries Limited. The CENMIRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of migraines
cenmira

General Information

Serial Number87237166
Word MarkCENMIRA
Filing DateTuesday, November 15, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 6, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of migraines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 21, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceutical Industries Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJerusalem 91010
IL
Party NameTeva Pharmaceutical Industries Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Trademark Events

Event DateEvent Description
Monday, January 6, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 6, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 28, 2019EXTENSION 4 GRANTED
Tuesday, May 28, 2019EXTENSION 4 FILED
Tuesday, May 28, 2019TEAS EXTENSION RECEIVED
Thursday, November 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 27, 2018EXTENSION 3 GRANTED
Tuesday, November 27, 2018EXTENSION 3 FILED
Tuesday, November 27, 2018TEAS EXTENSION RECEIVED
Saturday, May 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 24, 2018EXTENSION 2 GRANTED
Thursday, May 24, 2018EXTENSION 2 FILED
Thursday, May 24, 2018TEAS EXTENSION RECEIVED
Thursday, May 24, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 27, 2017EXTENSION 1 GRANTED
Monday, November 27, 2017EXTENSION 1 FILED
Monday, November 27, 2017TEAS EXTENSION RECEIVED
Tuesday, May 30, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 4, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 23, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 22, 2017ASSIGNED TO EXAMINER
Monday, November 21, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 18, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

cenmira migraines treatment preparations pharmaceutical